DOSSIER · 13F Holders · Q1 2026
Kiniksa Pharmaceuticals Intern
1 institutions still hold Kiniksa Pharmaceuticals Intern as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP G5269C101·1 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
1 institutions reported Kiniksa Pharmaceuticals Intern in Q1 2026. HARBOR CAPITAL ADVISORS, INC. leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.